Abstract:The antioxidant system of tumor cells severely impairs reactive oxygen species (ROS)-mediated tumor therapy. Despite extensive attempts to attenuate the antioxidant capacity by eliminating ROS scavengers such as glutathione (GSH), nicotinamide adenine dinucleotide phosphate (NADPH) over-expressed in the tumor microenvironment can regenerate GSH from glutathione disulfide (GSSG), hence weakening ROS-induced oxidative damage. Therefore, engineering a nanoplatform capable of depleting both NADPH and GSH is extremely significant for improving ROS-mediated tumor treatment. Herein, a synergetic antioxidant inhibition strategy is proposed to attenuate intracellular antioxidant capacity for hypoxic tumor therapy. In this context, both porous Prussian blue nanoparticles (PPB NPs) and cisplatin prodrug [cis-Pt (IV)] in the nanoplatform can oxidize GSH to directly reduce GSH levels, while PPB NPs also enable NADPH depletion by peroxidase-mimicking to impair GSH regeneration. Furthermore, PPB NPs with catalase-mimicking activity catalyze H 2 O 2 decomposition to alleviate tumor hypoxia, thus reducing the generation of GSH and boosting singlet oxygen ( 1 O 2 ) production by Chlorin e6 (Ce6) for enhancing oxidative damage. Experimental results prove that the nanoplatform, denoted as PPB-Ce6-Pt, can induce remarkable tumor cells apoptosis and ferroptosis. Importantly, a simple loading method and the use of Food Drug Administration (FDA)-approved materials make PPB-Ce6-Pt have great potential for practical applications. Statement of Significance The antioxidant system in tumor cells disables ROS-mediated tumor therapy. Besides, extensive attempts aim at depleting GSH without considering their regeneration. Therefore, we developed a synergetic strategy to attenuate intracellular antioxidant capacity for hypoxic tumor therapy. PPB-Ce6-Pt nanoplatform could not only directly reduce GSH levels but also deplete NADPH by peroxidase-mimicking to impair GSH regeneration. In addition, PPB-Ce6-Pt nanoplatform could catalyze H 2 O 2 decomposition to alleviate tumor hypoxia, thus reducing the generation of GSH and boosting 1 O 2 production by Chlorin e6 (Ce6) for increasing oxidative damage. Then, intracellular ROS boost and redox dyshomeostasis induced remarkable tumor cells apoptosis and ferroptosis. Importantly, a simple loading method and the use of biosafety materials made the nanoplatform have great potential for practical applications.

Regulating Signal Pathway Triggers Circular Reactive Oxygen Species Production to Augment Oxidative Stress with Enzyme-Activated Nanoparticles

Intelligent Nanocatalyst Mediated Lysosomal Ablation Pathway to Coordinate the Amplification of Tumor Treatment

Engineering a Synergistic Antioxidant Inhibition Nanoplatform to Enhance Oxidative Damage in Tumor Treatment

Regulation of Redox Balance Using a Biocompatible Nanoplatform Enhances Phototherapy Efficacy and Suppresses Tumor Metastasis

Tumor-targeted Hyaluronic Acid-Based Oxidative Stress Nanoamplifier with ROS Generation and GSH Depletion for Antitumor Therapy.

Modulating Intracellular Oxidative Stress Via Engineered Nanotherapeutics

Nanoparticles (Nps)-Mediated Targeted Regulation of Redox Homeostasis for Effective Cancer Therapy

Melanin Nanoparticle-Actuated Redox-State Perturbation and Temporally Photoactivated Thermal Stress for Synergistic Tumor Therapy

An Activatable Nanoenzyme Reactor for Coenhanced Chemodynamic and Starving Therapy Against Tumor Hypoxia and Antioxidant Defense System

Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy

Integrated energy conversion units in nanoscale frameworks induce sustained generation and amplified lethality of singlet oxygen in oxidative therapy of tumor

A porphyrin-MOF-based integrated nanozyme system for catalytic cascades and light-enhanced synergistic amplification of cellular oxidative stress

Amplification of Oxidative Stress Via Intracellular ROS Production and Antioxidant Consumption by Two Natural Drug-Encapsulated Nanoagents for Efficient Anticancer Therapy

An Oxidative Stress Nano-Amplifier for Improved Tumor Elimination and Combined Immunotherapy

PROTAC Nanoplatform with Targeted Degradation of NAD(P)H:Quinone Oxidoreductase 1 to Enhance Reactive Oxygen Species-Mediated Apoptosis

Reactive oxygen species-upregulating nanomedicines towards enhanced cancer therapy

Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy

Self-Supply Oxygen ROS Reactor via Fenton-like Reaction and Modulating Glutathione for Amplified Cancer Therapy Effect

Programmed Nanoreactors Boost Immune Response through ROS Cascade Amplification along with RNS Storm

Zinc-Based ROS Amplifiers Trigger Cancer Chemodynamic/Ion Interference Therapy Through Self-Cascade Catalysis

Redox-Active Polyphenol Nanoparticles Deprive Endogenous Glutathione of Electrons for ROS Generation and Tumor Chemodynamic Therapy